| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/10/1992 | US5095139 Fungicides |
| 03/10/1992 | US5095127 Process for producing polycyclic ether antibiotics |
| 03/10/1992 | US5095094 A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity |
| 03/10/1992 | US5094953 Human tissue plasminogen activator variants |
| 03/10/1992 | US5094951 Genetic engineering |
| 03/10/1992 | US5094947 Process for producing fructose-1,6-diphosphate |
| 03/10/1992 | CA1297055C Method for selectively increasing the ratio of single major components ofantibiotic a/40926 complex |
| 03/10/1992 | CA1297051C Expression of the cloned lysostaphin gene |
| 03/10/1992 | CA1297049C Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 03/08/1992 | CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process |
| 03/08/1992 | CA2050743A1 Expression of genes encoding plant pathogenesis related proteins in plant associated bacteria |
| 03/06/1992 | WO1992004441A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/06/1992 | CA2089752A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/05/1992 | WO1992004463A1 Cd58-specific monoclonal antibodies and their use |
| 03/05/1992 | WO1992003572A1 Method of preparing 17-oxosteroids |
| 03/05/1992 | WO1992003571A1 Process for producing 4-pregnene-3,20-dione and its derivatives |
| 03/05/1992 | WO1992003570A1 Monoclonal antibodies capable of binding to human and rat insulin |
| 03/05/1992 | WO1992003560A1 A method for rapid selection of efficient secretion vectors |
| 03/05/1992 | WO1992003556A1 PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM $i(TERMOTOGA MARITIMA) |
| 03/05/1992 | WO1992003548A1 Human zona pellucida protein zp3 |
| 03/05/1992 | WO1992003547A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
| 03/05/1992 | WO1992003541A1 A process for hydrolyzing hemicellulose by enzymes produced by trichoderma reesei |
| 03/05/1992 | WO1992003540A1 Enzymes with xylanolytic activity |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003477A1 Biologically active compound, a process for the preparation thereof and use of the same |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/05/1992 | WO1992003157A1 Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 03/05/1992 | WO1992003128A1 Pharmaceutical compositions with mucolytic and antitussive activity containing (-)-trans-sobrerol |
| 03/05/1992 | WO1991015516A3 Hepatitis c virus epitopes |
| 03/05/1992 | CA2090337A1 Enzymes with xylanolytic activity |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2081770A1 A cd58-specific monoclonal antibody and the use thereof |
| 03/05/1992 | CA2066160A1 Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge |
| 03/04/1992 | EP0473328A2 Biological process for preparing optically active lactic acid |
| 03/04/1992 | EP0473253A1 Mammalian centromere containing human DNA sequences associated with a dominant marker |
| 03/04/1992 | EP0473222A2 PHB-free gellan gum broth |
| 03/04/1992 | EP0473217A1 Gram-negative alkaliphilic microorganisms |
| 03/04/1992 | EP0473210A2 Recombinant Marek's disease virus |
| 03/04/1992 | EP0473128A2 Monoclonal antibody specifically reactive with human perforin |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0473094A2 Process for producing L-tryptophan |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/04/1992 | EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto |
| 03/04/1992 | EP0472947A1 Process for producing amino acids |
| 03/04/1992 | EP0472869A2 Plasmids of corynebacterium glutamicum and derived plasmid vectors |
| 03/04/1992 | EP0472678A1 Nitrate reductase derived from yeasts, its production and use. |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472659A1 T-lymphotropic retrovirus monoclonal antibodies |
| 03/04/1992 | EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 03/04/1992 | EP0472638A1 Method for isolating receptors having a preselected specificity |
| 03/04/1992 | EP0472599A1 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 03/04/1992 | EP0328542B1 Antiparathyroid antibody preparation |
| 03/03/1992 | US5093338 Lipophilic macrolide useful as an immunosuppressant |
| 03/03/1992 | US5093261 Monoclonal antibodies |
| 03/03/1992 | US5093257 Hybrid prokaryotic polypeptides produced by in vivo homologous recombination |
| 03/03/1992 | US5093256 Essentially purified, thermostable and alkalophilic lipase from bacillus sp. a30-1 atcc 53841 |
| 03/03/1992 | US5093247 Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
| 03/03/1992 | US5093246 Rna ribozyme polymerases, dephosphorylases, restriction endoribo-nucleases and methods |
| 03/03/1992 | US5093244 Thymidine or thymine by fermentation of brevibacterium mutant |
| 03/03/1992 | US5093243 Process for the separation and recovery of nosiheptide |
| 03/03/1992 | US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna |
| 03/03/1992 | US5093115 Method of preparing activated killer monocytes for treating colorectal cancer |
| 03/03/1992 | CA1296669C Substance gif-2 and process for production of the same |
| 03/03/1992 | CA1296666C Bacillus thuringiensis isolate |
| 03/03/1992 | CA1296662C Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 03/03/1992 | CA1296661C Monoclonal antibodies specific for synthetic glycosphingolipids |
| 03/03/1992 | CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
| 03/03/1992 | CA1296604C Method for releasing rna and dna from cells |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992003559A2 Test system for checking the activity of viral proteinases |
| 03/01/1992 | WO1992003471A1 New insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | WO1992003470A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090705A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090702A1 Insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2072154A1 Test system for checking the activity of viral proteinases |
| 03/01/1992 | CA2067249A1 Method for rapid selection of efficient secretion vectors |
| 03/01/1992 | CA2049883A1 Monoclonal antibody specifically reactive with human perforin |
| 02/28/1992 | WO1992003538A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/26/1992 | EP0472494A2 Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics |
| 02/26/1992 | EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy |
| 02/26/1992 | EP0472286A1 Gene encoding candida albicans plasma membrane H+ATPase |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
| 02/26/1992 | EP0472005A1 Antiviral antibiotic BU-4224V |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/26/1992 | EP0211037B1 METHOD OF PRODUCING HIGH MOLECULAR WEIGHT SODIUM HYALURONATE BY FERMENTATION OF $i(STREPTOCOCCUS) |
| 02/25/1992 | US5091524 Glycosidase inhibitor salbostatin, process for its preparation, and its use |
| 02/25/1992 | US5091511 Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it |
| 02/25/1992 | US5091418 Novel alpha-glucosidase inhibitor, pradimicin Q |